Tempus AI Stock Extends A 6-Day Losing Streak To A 25% Loss
Shares of Tempus AI (TEM) have closed lower in each of the last 6 sessions, a cumulative decline of 24.9%. That erased about $3.8 billion from the company’s market value, which now stands at about $11.5 billion. The stock closed at $63.43 on Tuesday, November 17, 25.4% below its 52-week high of $85.08 and 52.7% above its low of $41.55.

How The Streak Stacks Up Against The S&P 500
Returns for TEM and the S&P 500 over the streak and the periods around it, all ending Tuesday, November 17 and including dividends:
| Return Period | TEM | S&P 500 |
|---|---|---|
| 1 Day | -2.1% | -1.0% |
| 6 Days (Current Streak) | -24.9% | -2.7% |
| 1 Month (21 Trading Days) | -1.4% | -4.5% |
| 3 Months (63 Trading Days) | 3.6% | -4.5% |
| Year To Date | 7.4% | 8.3% |
| 1 Year (252 Trading Days) | -7.4% | 10.3% |
A Stock-Specific Slide, Or A Market Move?
Over the same 6 trading days, the S&P 500 returned -2.7% including dividends, so the slide is mostly Tempus AI’s own story rather than the market’s. Over the past three months the stock is up 3.6%, a window that includes the streak; over the other 57 sessions of that window it was up 37.9%.
What The Numbers Say About The Slide
On the fundamentals, revenue grew 36.6% over the last twelve months, against a median of 7.9% for S&P 500 Health Care stocks; and its operating margin is -18.5%, versus a median of 17.4%. Tempus AI does not have positive trailing earnings, so there is no meaningful price-to-earnings multiple to compare. The fundamentals give the sellers some support: an operating loss.
A slide like this raises an obvious follow-up: which marked-down stocks are actually worth buying? Our Buy the Dip screen runs that test every day, flagging beaten-down names whose fundamentals still hold up.
Falling Prices Test Conviction. Rules Do Not Flinch
A losing streak forces a choice on every holder: sell into weakness, average down, or freeze. All three are emotional answers to what should be an analytical question, and decisions made that way tend to be expensive ones.
The Trefis High Quality (HQ) Portfolio takes the emotion out: about 30 quality businesses screened for the fundamentals that survive bad stretches, held and rebalanced by rules. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Let the rules decide, not the tape.